Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,384,615
Closed -$20M 86
2024
Q1
$20M Buy
+15,384,615
New +$16.1M 0.25% 57
2021
Q1
Sell
-2,742,271
Closed -$15.7M 96
2020
Q4
$15.7M Sell
2,742,271
-8,068,666
-75% -$51.3M 0.22% 60
2020
Q3
$71.9M Buy
+10,810,937
New +$96.3M 1.32% 27
2015
Q3
Sell
-73,441
Closed -$1.67M 63
2015
Q2
$1.67M Sell
73,441
-54,182
-42% -$1.33M 0.17% 40
2015
Q1
$3.23M Buy
127,623
+2,280
+2% +$62.8K 0.32% 37
2014
Q4
$3.09M Buy
+125,343
New +$3.21M 0.33% 33

Other funds holding VXRT

RA Capital Management's VXRT Position: Q2 2024 in Review

RA Capital Management sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 15,384,615 shares — an estimated $20M sold.

RA Capital Management first reported a position in VXRT in Q4 2014 and held it in 6 quarters. The position peaked at $71.9M in Q3 2020. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

  • RA Capital Management reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
  • RA Capital Management sold 15,384,615 Vaxart shares in Q2 2024, an estimated $20M.
  • RA Capital Management first reported a position in Vaxart in Q4 2014 and held it in 6 quarters.
  • RA Capital Management's Vaxart position peaked at $71.9M in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on RA Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.